173 related articles for article (PubMed ID: 35509856)
1. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
[TBL] [Abstract][Full Text] [Related]
2. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
Wang B; Wang W; Wang H; Liu W
Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis identifies potential biomarkers involved in the metastasis of locoregionally advanced nasopharyngeal carcinoma.
Hu R; Xu X; Mo L; Chen M; Liu Y
Medicine (Baltimore); 2022 Sep; 101(35):e30126. PubMed ID: 36107539
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
[TBL] [Abstract][Full Text] [Related]
5. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
Tai J; Park J; Han M; Kim TH
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
7. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Liu J; Li X; Yang S; Mou J; Lu H
Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
9. Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study.
Chen J; Yang R; Zhang W; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2026-32. PubMed ID: 25973099
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
12. Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis.
Zhong X; Shang J; Zhang R; Zhang X; Yu L; Niu H; Duan X
PLoS One; 2024; 19(5):e0296034. PubMed ID: 38753689
[TBL] [Abstract][Full Text] [Related]
13. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.
Ge Y; He Z; Xiang Y; Wang D; Yang Y; Qiu J; Zhou Y
Mol Biol Rep; 2019 Jun; 46(3):2829-2840. PubMed ID: 30830589
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
Zhang JZ; Wu ZH; Cheng Q
Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Song Y; Feng T; Cao W; Yu H; Zhang Z
Comput Intell Neurosci; 2022; 2022():9022700. PubMed ID: 35712071
[TBL] [Abstract][Full Text] [Related]
16. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
[TBL] [Abstract][Full Text] [Related]
17. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
18. The Highly Expressed IFIT1 in Nasopharyngeal Carcinoma Enhances Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Wu X; Lin L; Zhou F; Yu S; Chen M; Wang S
Mol Biotechnol; 2022 Jun; 64(6):621-636. PubMed ID: 35038119
[TBL] [Abstract][Full Text] [Related]
19. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
20. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
